TP53 and renal cell carcinoma: It could also explain why VHL-deficient cells of RCC are resistant to chemotherapy even if they exhibit wild-type p53; however, it also brought new questions regarding a potential, more general role of VHL in p53-mediated stress response, particularly, in the case of other types of cancers.